A chemical and computational approach to comprehensive glycation characterization on antibodies

Non-enzymatic glycation is a challenging post-translational modification to characterize due to the structural heterogeneity it generates in proteins. Glycation has become increasingly recognized as an important product quality attribute to monitor, particularly for the biotechnology sector, which produces recombinant proteins under conditions that are amenable to protein glycation. The elucidation of sites of glycation can be problematic using conventional collision-induced dissociation (CID)-based mass spectrometry because of the predominance of neutral loss ions. A method to characterize glycation using an IgG1 monoclonal antibody (mAb) as a model is reported here. The sugars present on this mAb were derivatized using sodium borohydride chemistry to stabilize the linkage and identified using CID-based MS2 mass spectrometry and spectral search engines. Quantification of specific glycation sites was then done using a targeted MS1 based approach, which allowed the identification of a glycation hot spot in the heavy chain complementarity-determining region 3 of the mAb. This targeted approach provided a path forward to developing a structural understanding of the propensity of sites to become glycated on mAbs. Through structural analysis we propose a model in which the number and 3-dimensional distances of carboxylic acid amino acyl residues create a favorable environment for glycation to occur.

[1]  L. Maillard,et al.  Action des acides amines sur les sucres : formation des melanoidines par voie methodique , 1912 .

[2]  H. Isbell,et al.  Mutarotation, Hydrolysis, and Rearrangement Reactions of Glycosylamines1 , 1958 .

[3]  H. Dixon,et al.  Carbonyl-amine reactions in protein chemistry. , 1975, Advances in protein chemistry.

[4]  P. Higgins,et al.  Reaction of monosaccharides with proteins: possible evolutionary significance. , 1981, Science.

[5]  J. Baynes,et al.  The Amadori product on protein: structure and reactions. , 1989, Progress in clinical and biological research.

[6]  A. Acharya,et al.  Aldimine to ketoamine isomerization (Amadori rearrangement) potential at the individual nonenzymic glycation sites of hemoglobin a: Preferential inhibition of glycation by nucleophiles at sites of low isomerization potential , 1991, Journal of protein chemistry.

[7]  J. Porath,et al.  Selective adsorption of immunoglobulins and glucosylated proteins on phenylboronate-agarose. , 1992, Journal of chromatography.

[8]  J. Yates,et al.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database , 1994, Journal of the American Society for Mass Spectrometry.

[9]  J. Baynes,et al.  Role of the Maillard Reaction in Aging of Tissue Proteins , 1998, The Journal of Biological Chemistry.

[10]  W. Scouten,et al.  Boronate affinity chromatography. , 2015, Methods in molecular biology.

[11]  P. Balaram,et al.  Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement. , 2001, Chemistry & biology.

[12]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[13]  L. Björck,et al.  IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G , 2002, The EMBO journal.

[14]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[15]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[16]  Matthew J. Sniatynski,et al.  Multiple neutral loss monitoring (MNM): A multiplexed method for post-translational modification screening , 2006, Journal of the American Society for Mass Spectrometry.

[17]  Alain Balland,et al.  Characterization of nonenzymatic glycation on a monoclonal antibody. , 2007, Analytical chemistry.

[18]  Richard D. Smith,et al.  Enrichment and analysis of nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry. , 2007, Journal of proteome research.

[19]  Ronald J. Moore,et al.  A method for selective enrichment and analysis of nitrotyrosine-containing peptides in complex proteome samples. , 2007, Journal of proteome research.

[20]  Richard D. Smith,et al.  Application of electron transfer dissociation mass spectrometry in analyses of non-enzymatically glycated peptides. , 2007, Rapid communications in mass spectrometry : RCM.

[21]  Richard D. Smith,et al.  Analysis of non-enzymatically glycated peptides: neutral-loss-triggered MS(3) versus multi-stage activation tandem mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[22]  Ron Taticek,et al.  A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior. , 2008, Analytical biochemistry.

[23]  Inn Yuk,et al.  Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody. , 2008, Analytical chemistry.

[24]  Markus Brosch,et al.  Accurate and sensitive peptide identification with Mascot Percolator. , 2009, Journal of proteome research.

[25]  Alexander Scherl,et al.  Glycation Isotopic Labeling with 13C-Reducing Sugars for Quantitative Analysis of Glycated Proteins in Human Plasma* , 2009, Molecular & Cellular Proteomics.

[26]  Jean-Charles Sanchez,et al.  Strategies for proteomic analysis of non-enzymatically glycated proteins. , 2009, Mass spectrometry reviews.

[27]  Bruce A Kerwin,et al.  Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody. , 2011, Journal of pharmaceutical sciences.

[28]  V. Katta,et al.  Rapid identification of low level glycation sites in recombinant antibodies by isotopic labeling with 13C6-reducing sugars. , 2012, Analytical chemistry.

[29]  Alain Van Dorsselaer,et al.  Characterization of therapeutic antibodies and related products. , 2013, Analytical chemistry.

[30]  François Debaene,et al.  Analytical characterization of biosimilar antibodies and Fc-fusion proteins , 2013 .

[31]  C. Fritsch,et al.  Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab , 2013, BioDrugs.

[32]  Ying Zhang,et al.  A new tool for monoclonal antibody analysis , 2014, mAbs.

[33]  Hongcheng Liu,et al.  Identification and comparative quantitation of glycation by stable isotope labeling and LC-MS. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  Hongcheng Liu,et al.  In vitro and in vivo modifications of recombinant and human IgG antibodies , 2014, mAbs.

[35]  Tilman Schlothauer,et al.  Assessment of chemical modifications of sites in the CDRs of recombinant antibodies , 2014, mAbs.

[36]  D. Guillarme,et al.  Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach. , 2015, Journal of pharmaceutical and biomedical analysis.